Kernicterus & Newborn Jaundice

What is kernicterus?

Kernicterus is permanent brain damage caused by severe newborn jaundice that was not treated in time. When the pigment bilirubin rises to dangerous levels in a newborn’s blood, it can cross into the brain and injure the basal ganglia and brainstem, the regions that control movement, hearing, and eye movements. The medical name for this injury spectrum is bilirubin-induced neurologic dysfunction (BIND); kernicterus is its severe, chronic form.

Two facts define kernicterus in both medicine and law. First, it is rare, but it has not disappeared, and cases continue to be reported in the United States. Second, it is regarded by patient-safety authorities as almost always preventable: routine bilirubin screening, timely phototherapy, and, in severe cases, exchange transfusion can nearly always stop jaundice before it injures the brain.

Jaundice vs. kernicterus: an important difference

About 60% of full-term newborns and 80% of preterm newborns develop some jaundice in the first week of life: a yellow tint to the skin and eyes as the body clears bilirubin, a normal byproduct of red blood cell turnover. In the vast majority of babies, jaundice is harmless and resolves with monitoring or simple treatment.

Kernicterus is what happens when that ordinary, manageable condition is allowed to escalate: bilirubin keeps climbing, nobody measures it (or nobody acts on the measurement), and the pigment becomes concentrated enough to poison brain tissue. Jaundice is a symptom to be watched. Kernicterus is an outcome that watching is supposed to prevent.

How untreated jaundice becomes kernicterus

Several factors can push a newborn’s bilirubin from routine to dangerous:

• Hemolytic disease: blood-type incompatibility between mother and baby (Rh or ABO incompatibility) that destroys red blood cells faster than the liver can process the resulting bilirubin.
• Prematurity: a preterm liver clears bilirubin more slowly, and a preterm brain is injured at lower bilirubin levels.
• G6PD deficiency: an inherited enzyme deficiency and a leading contributor to kernicterus cases in the U.S.
• Feeding problems and dehydration: inadequate intake slows bilirubin elimination.
• Bruising during delivery: cephalohematoma or extensive bruising from a difficult delivery adds a bilirubin load as the blood is broken down.
• Early discharge without follow-up: bilirubin typically peaks at 3 to 5 days of life, after most families are home. Discharge without a measured bilirubin level and a scheduled follow-up is a recognized failure point.

None of these risk factors is exotic. Each one is exactly what newborn screening protocols exist to catch.

Warning signs and symptoms

Early (acute bilirubin encephalopathy, still treatable)

• Deepening jaundice spreading down the body toward the legs
• Extreme sleepiness or lethargy; difficulty waking to feed
• Poor sucking or refusal to feed
• A high-pitched, inconsolable cry
• “Floppy” muscle tone (hypotonia)

Intermediate to advanced (a medical emergency)

• Arching of the head, neck, and back (retrocollis and opisthotonos)
• Increasing muscle stiffness (hypertonia)
• Fever, seizures, apnea

If a jaundiced newborn shows any of the intermediate signs, immediate treatment is the standard of care, and watchful observation falls short of it. Brain injury at this stage is measured in hours.

Chronic kernicterus (the permanent condition)

• Athetoid or dystonic cerebral palsy: writhing, involuntary movements
• Sensorineural hearing loss, up to deafness (auditory pathways are especially vulnerable)
• Upward-gaze palsy and other eye-movement abnormalities
• Dental enamel dysplasia in baby teeth
• Intelligence is often preserved: many children with kernicterus understand far more than their bodies allow them to express

Bilirubin danger levels

Treatment decisions follow the American Academy of Pediatrics (AAP) 2022 hyperbilirubinemia guideline, which sets thresholds by the baby’s age in hours, gestational age, and risk factors. The figures below are approximate reference points for healthy term newborns without risk factors: the exact threshold for any baby comes from the AAP nomograms, and risk factors lower it.

Every one of these numbers is knowable with a heel-stick blood test or a transcutaneous meter reading that takes seconds. The AAP recommends every newborn be screened with a measured bilirubin level before hospital discharge: visual inspection alone is not reliable, particularly in babies with darker skin tones.

The treatment that should have happened

1. Screening. A measured bilirubin level (blood or transcutaneous) before discharge, plotted on the hour-specific nomogram, with follow-up scheduled based on the result.
2. Phototherapy. Blue-green light converts bilirubin in the skin into forms the body can excrete without the liver’s help. Started at guideline thresholds, phototherapy almost always stops the rise safely.
3. IVIG. In blood-type incompatibility cases, intravenous immunoglobulin can slow red-cell destruction.
4. Exchange transfusion. The emergency measure: the baby’s blood is replaced in small increments, removing bilirubin directly. Indicated when levels reach exchange thresholds or any neurological signs appear.

The tragedy of kernicterus is that this ladder works. Cases almost never come from treatment failing. They come from treatment starting too late or never starting at all.

Long-term effects and lifetime costs

Kernicterus is permanent; treatment from this point is about maximizing function, since the damage itself cannot be reversed. Depending on severity, a child may need movement therapy and adaptive equipment for athetoid cerebral palsy, cochlear implants or hearing support, augmentative communication devices, vision therapy, and lifelong attendant care. Federal courts and life-care planners in kernicterus cases routinely project lifetime costs in the millions of dollars, which is why compensation matters: it is the difference between care rationed by insurance and care planned around the child.

Was it preventable? What the standard of care requires

Patient-safety organizations have treated kernicterus as a “never event” category of harm for two decades. The standard of care expects clinicians to:

• Assess every newborn’s jaundice risk before discharge, including blood type screening and G6PD consideration where indicated
• Measure, not eyeball, bilirubin before discharge and plot it by hour of life
• Schedule follow-up within 1–3 days for babies discharged before bilirubin peaks
• Take parents’ reports of poor feeding, sleepiness, or deepening yellow color seriously
• Start phototherapy at guideline thresholds and escalate without delay when levels keep rising

When kernicterus happens anyway, it is almost always because one or more of those steps was skipped: a baby discharged without a bilirubin test, a lab result never communicated, a worried parent’s call answered with reassurance instead of a repeat level, an emergency-room visit where jaundice was noted but not measured.

Not every case of kernicterus is malpractice. Rare causes, like Crigler-Najjar syndrome, can defeat even proper care. But because the preventable causes are so common and the prevention so straightforward, kernicterus cases deserve records review more than almost any other birth injury.

Legal options for families

A kernicterus claim is a medical-negligence claim: it asks whether the care your baby received fell below the accepted standard, and whether that failure caused the injury. In practice, our attorneys and independent medical experts look for the documented failure points: the missing pre-discharge bilirubin test, the unplotted lab value, the follow-up that was never scheduled, the emergency visit where treatment was delayed.

Compensation in these cases can cover lifetime medical and attendant care, therapy and equipment, lost future earnings, home and vehicle modification, and the family’s out-of-pocket losses. Deadlines (statutes of limitations) vary by state, and special rules apply to claims involving military hospitals or federally funded clinics: our legal process guides explain them state by state.

Where your case would be handled depends on where the care happened: Banville Law attorneys are licensed in New York and Washington, D.C.; The Weitz Firm attorneys are licensed in Pennsylvania and New Jersey; elsewhere, the alliance connects families with its vetted network of local birth injury attorneys.

Frequently asked questions

Can kernicterus be cured?

No. Once bilirubin has damaged brain tissue, the injury is permanent. Treatment focuses on maximizing function (therapy, hearing restoration, communication support), which is exactly why lifetime-care funding matters.

At what bilirubin level does kernicterus occur?

Risk rises sharply as total serum bilirubin exceeds 25 mg/dL in term newborns, and at lower levels in premature or ill babies. There is no single “safe” number, which is why the standard of care keys treatment to hour-specific thresholds well below the danger zone.

My child has athetoid cerebral palsy and hearing loss. Could it be kernicterus?

That combination (movement disorder plus sensorineural hearing loss, often with preserved intelligence and a history of newborn jaundice) is the classic kernicterus pattern. A records review can usually establish whether severe hyperbilirubinemia occurred and how it was handled.

How long do I have to file a kernicterus lawsuit?

It depends on your state. Many states pause (toll) the deadline for claims brought on behalf of a child, sometimes into their teens, but parents’ own claims and some notice requirements can expire in as little as one to two years. Confirm your state’s deadline early.

What does a case review cost?

Nothing. The review is free, and kernicterus cases are handled on contingency: attorney fees come only from a recovery, never from your pocket.

Go deeper on kernicterus

• What causes kernicterus
• Kernicterus symptoms, phase by phase
• Long-term effects of kernicterus
• Dangerous bilirubin levels (reference charts)
• Newborn jaundice malpractice
• Kernicterus settlements

Sources

This page is for general education and is not medical advice. Medical facts above are drawn from the cited primary sources; legal statements reflect the reviewing attorneys’ professional experience. Always consult your child’s physician about medical concerns.